Heather Emily Stefanski MD
Assistant Professor, Pediatrics, University of Minnesota Medical School
Join to View Full Profile
MMC 366University of MinnesotaMinneapolis, MN 55455
Phone+1 612-626-2961
Dr. Stefanski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2007 - 2010- University of MinnesotaResidency, Pediatrics, 2004 - 2007
- University of Minnesota Medical SchoolClass of 2004
Certifications & Licensure
GA State Medical License 2025 - 2026
MN State Medical License 2006 - 2025
WA State Medical License 2025 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.Rakesh Awasthi, Stephan A Grupp, Edward R Waldron, Gregory A Yanik, Constantine S Tam
Blood Advances. 2025-09-09 - Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.Monzr M Al Malki, Stephanie Bo-Subait, Brent Logan, Janelle Olson, Jianqun Kou
Journal of Clinical Oncology. 2025-09-01 - 2 citationsCurrent Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.Stephen R Spellman, Ke Xu, Temitope Oloyede, Kwang Woo Ahn, Othman Akhtar
Transplantation and Cellular Therapy. 2025-08-01
Journal Articles
- Thymic Epithelial Cell Support of Thymopoiesis Does Not Require KlothoBruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology
Press Mentions
Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical TrialsJanuary 11th, 2021- National Marrow Donor Program® (NMDP)/Be the Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access to TransplantSeptember 27th, 2023
Grant Support
- BMT Core - Pediatric Transplantation and Cellular Therapy Consortium (PTCTC): Providing Clinical Trial Access For Children With Life Threatening DiseasesNATIONAL MARROW DONOR PROGRAM2024–2031
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
